Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study
Lijun Zhao(Sichuan University), Fang Liu(Second Military Medical University), Chuanyi Zhao(Union Hospital), Yucheng Wu(Sichuan University), Xuegui Ju(Sichuan University), Yujia Wang(Qingdao University), Qianqian Han(Sichuan University), Linqiao Tang(Sichuan University), Qingyue Zeng(West China Medical Center of Sichuan University), Xiaoqin Zhou(Sichuan University), Ke Liu(Hubei University of Arts and Science), Xiang Xiao(Sichuan University), Yutong Zou(Sichuan University), Xingyuan Li(Sichuan University)
Cited by 8
Related Papers
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action
|Molecular Cancer|2009|131
Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk
|Frontiers in Immunology|2024|92
Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice
|Journal of Biological Chemistry|2016|64